Achiko AG Announces Financial Results for Six Months Ended June 30, 2020 - Seite 2

Teman Sehat now has over 40,000 registered users and is used in over 800 locations since the launch in June and roll out in July in Pekanbaru, Indonesia. The Company recently signed a contract with UltraVouchers, which, if successful, gives places such as shopping malls, hospitals, schools, parks and the like the ability to monetize check-ins through microtransactions and coupons. The Company is looking to expand the footprint of Teman Sehat to other locations in Indonesia and beyond, coupled along with Gumnuts.

Gumnuts is a novel Covid-19 testing technology licensed from Regenacellx.sl. Led by Dr. Michael Edel, Chief Scientist and developer of Gumnuts, the technology may transform the approach to tackling the Covid-19 pandemic with a very low cost, simple and convenient saliva-based test delivering results under 5 minutes. The testing technology is the subject of a provisional patent, has successfully been tested in-vitro, and Achiko is now proceeding to clinical evaluation trials, sourcing manufacturing locations, proceeding to respective approvals in Asia, Europe and the Americas and developing a sales and marketing pipeline. The Company is looking forward to consolidating recent gains and updating its compliance obligations.

The 2020 half-year report is available in the Media and Investor section of the website https://www.achiko.com

ABOUT ACHIKO AG
Headquartered in Switzerland, with a global market focus, Achiko AG (ISIN CH0522213468) is an entrepreneurial platform company, utilizing the knowledge and experience of its people and key technologies to enable transformation in various industries.

Through innovations in technology and regulation along with the company’s unique operating footprint from Europe to Asia, Achiko seeks to transform markets and bring unique value to its customers, people, and shareholders. Achiko’s core platform consists of user registration and payment services which are accessible to application developers. A messaging service and other community based social features are being launched in late 2020. Achiko supports innovations in healthcare through its Teman Sehat (“Health Buddy”) ecosystem, its Gumnuts novel saliva Covid-19 testing technology based on DNA aptamers developed with Regenacellx.sl, as well as consumer payments and finance and games and entertainment.